Articles with public access mandates - George PentheroudakisLearn more
Available somewhere: 19
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
Mandates: Cancer Research UK, National Institute for Health Research, UK
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
A Krämer, T Bochtler, C Pauli, G Baciarello, S Delorme, K Hemminki, ...
Annals of Oncology 34 (3), 228-246, 2023
Mandates: European Commission
ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe
I Vaz-Luis, M Masiero, G Cavaletti, A Cervantes, RT Chlebowski, ...
Annals of oncology 33 (11), 1119-1133, 2022
Mandates: US National Institutes of Health, V Foundation, USA, Susan G. Komen
Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper
PG Casali, P Bruzzi, J Bogaerts, JY Blay, M Aapro, A Adamous, A Berruti, ...
Annals of Oncology 26 (2), 300-306, 2015
Mandates: Cancer Research UK
Heterogeneity in cancer guidelines: should we eradicate or tolerate?
G Pentheroudakis, R Stahel, H Hansen, N Pavlidis
Annals of Oncology 19 (12), 2067-2078, 2008
Mandates: US National Institutes of Health
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
B Gyawali, EGE De Vries, U Dafni, T Amaral, J Barriuso, J Bogaerts, ...
ESMO open 6 (3), 100117, 2021
Mandates: Cancer Research UK
Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus
C Buske, M Dreyling, A Alvarez-Larrán, J Apperley, L Arcaini, C Besson, ...
ESMO open 7 (2), 100403, 2022
Mandates: German Research Foundation, National Institute for Health Research, UK …
Evaluation of CpG island methylator phenotype as a biomarker in colorectal cancer treated with adjuvant oxaliplatin
SA Cohen, C Wu, M Yu, G Gourgioti, R Wirtz, G Raptou, C Gkakou, ...
Clinical colorectal cancer 15 (2), 164-169, 2016
Mandates: US National Institutes of Health
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review
A Prelaj, V Miskovic, M Zanitti, F Trovo, C Genova, G Viscardi, SE Rebuzzi, ...
Annals of Oncology, 2023
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome Trust
In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients
M Vassilakopoulou, T Togun, U Dafni, H Cheng, J Bordeaux, ...
PLoS One 9 (6), e99131, 2014
Mandates: US National Institutes of Health
COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)
L Castelo-Branco, Z Tsourti, S Gennatas, J Rogado, M Sekacheva, ...
ESMO open 7 (3), 100499, 2022
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Establishment of CORONET, COVID-19 risk in oncology evaluation tool, to identify patients with cancer at low versus high risk of severe complications of COVID-19 disease on …
RJ Lee, O Wysocki, C Zhou, R Shotton, A Tivey, L Lever, J Woodcock, ...
JCO clinical cancer informatics 6, e2100177, 2022
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases
SA Cohen, M Yu, K Baker, M Redman, C Wu, TJ Heinzerling, RM Wirtz, ...
Clinical epigenetics 9, 1-8, 2017
Mandates: US National Institutes of Health
ESMO Expert Consensus Statements on the management of breast cancer during pregnancy (PrBC)
S Loibl, HA Azim Jr, T Bachelot, P Berveiller, A Bosch, E Cardonick, ...
Annals of Oncology 34 (10), 849-866, 2023
Mandates: European Commission
The systemic pro-inflammatory response: targeting the dangerous liaison between COVID-19 and cancer
GM Dettorre, M Patel, A Gennari, G Pentheroudakis, E Romano, ...
ESMO open 6 (3), 100123, 2021
Mandates: Cancer Research UK, National Institute for Health Research, UK, Wellcome Trust
Embolotherapy for hepatic oncology: current perspectives and future directions
R Bajwa, DC Madoff, SA Kishore
Digestive disease interventions 4 (02), 134-147, 2020
Mandates: US National Institutes of Health
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
A Cortellini, GM Dettorre, U Dafni, J Aguilar-Company, L Castelo-Branco, ...
Journal for immunotherapy of cancer 10 (11), 2022
Mandates: National Institute for Health Research, UK
An international comparison of presentation, outcomes and CORONET predictive score performance in patients with cancer presenting with COVID-19 across different pandemic waves
O Wysocki, C Zhou, J Rogado, P Huddar, R Shotton, A Tivey, L Albiges, ...
Cancers 14 (16), 3931, 2022
Mandates: Cancer Research UK, UK Medical Research Council, National Institute for …
Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain
F Roitberg, T Amaral, NI Cherny, R Giuliani, NJ Latino, M Galotti, G Bricalli, ...
Esmo Open 8 (5), 101617, 2023
Mandates: European Commission
Publication and funding information is determined automatically by a computer program